Concourse Financial Group Securities, Inc. Moderna, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 650 shares of MRNA stock, worth $24,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650
Previous 801
18.85%
Holding current value
$24,862
Previous $95,000
54.74%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.62 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.54 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$978 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$644 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$276 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...